2 participants
Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-06-15
- Start Date:
- 2015-10-08
- Completion:
- 2017-07-30
Conditions
- Refractory Solid Tumors
Interventions
- DRUG
No Results Yet